… spent $30.2 billion on specialty autoimmune medicines like Rasuvo, Humira, and Enbrel in 2015, according to IMS Health, and spending on autoimmune treatments grew 28% from the prior year-more quickly than any other treatment category. Koios’s …
Category: Patent / Trademark Law
Koios Pharmaceuticals Receives Favorable Ruling in Challenge to High-Cost Druga s Patent
… spent $30.2 billion on specialty autoimmune medicines like Rasuvo, Humira, and Enbrel in 2015, according to IMS Health, and spending on autoimmune treatments grew 28% from the prior year-more quickly than any other treatment category. Koios’s …
Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR
Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the issuance on January 31, 2017 of an eighth patent by the United States Patent and Trademark Office covering Trokendi XR, its novel once-daily extended-release topiramate product. The patent provides protection for the product with expiration that is no earlier than 2027.
Coherus BioSciences Files Four Petitions for Inter Partes Review…
Coherus BioSciences, Inc. , today announced that it has filed four petitions for Inter Partes Review in the United States Patent and Trademark Office seeking invalidation of AbbVie’s U.S. Patent 9,085,619 . The ‘619 patent is generally directed to formulations of adalimumab that do not contain a buffer.
Tyme Announces Issuance of Second Core Platform Patent
Tyme Technologies, Inc. , a clinical stage biotechnology company developing cancer therapeutics that are designed to be effective across multiple tumor types, announced that the USPTO has issued patent number 9,549,969 . This substantially expands on issued patent number 8,481,498 in respect to using tyrosine derivatives in combination with agents that may increase oxidative stress to cause tumor cell death.
Marijuana brands can trademark almost anything, except marijuana
Its logo – “hi” in white letters inside an orange circle – can be found above the front door of a Portland, Ore., marijuana shop and on a handful of cannabis products, including massage oil and Hi Releaf pain-relief balm. But you wouldn’t guess any of that from Hi’s trademark filings.
Cellect Receives Patent Notice of Allowance from US Patent &…
Cellect Biotechnology Ltd. , a developer of stem cells isolation technology, announces today that it has received a formal notice of allowance around a key method of treatment patent from the United States Patent & Trademark Office. The allowed claims relate to the engineering of regulatory immune cells with enhanced apoptotic activity to be used for immunomodulation for treating or preventing immune related disorders.
Marijuana brands can trademark almost anything, except marijuana
Hal Lewis, national sales director for Cannabis Sativa Inc., with Hi-brand cannabis balm and other products. Hi is a cannabis brand.